From the Editor-in-Chief

Increased vaccination rates can help reduce cervical cancer as a worldwide health threat.

by William G. Nelson, MD, PhD

Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development.

by Marci A. Landsmann

Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.

by Ashley P. Taylor

Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.

by Marci A. Landsmann

A study adds to evidence that many patients with ductal carcinoma in situ do not need to have their lymph nodes removed.

by Cheryl Platzman Weinstock

In a study of women with breast cancer in North Carolina, those who lived in rural areas or were black were more likely than urban white women to report negative changes in their employment.

by Pamela Rafalow Grossman

Cancer patients often do not understand words their doctors use while talking about chemotherapy, but a new video series helps explain these terms.

by Jen Tota McGivney

Patients with advanced cancer often go to rehabilitation facilities after a hospital stay in hopes of gaining the strength for further treatment, but the majority do not go on to receive additional cancer therapy, a study reports.

by Ashley P. Taylor

Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.

by Emma Yasinski

A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.

by Bradley D. Miller, PhD